Clinical Trial Update: Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mitoxantrone with clofarabine for recurrent non-Hodgkin lymphoma or acute leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Burkitt Lymphoma Leukemia
• Diffuse Large B-cell Lymphoma
• Lymphoblastic Lymphoma

Drugs mentioned

• Clofarabine (clofarabine)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: New York Medical College | Conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: COMPLETED